In clinical settings, the SLC45A2 gene is of interest due to its implications in various pigmentation disorders. Beyond albinism, variations in this gene have been associated with differences in skin color among different populations. Additionally, SLC45A2 has been studied for its role in melanoma, a type of skin cancer originating from melanocytes, where altered expression levels might influence tumor progression and prognosis.
